Cite
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO‐idel).
MLA
Eyre, Toby A., et al. “A Retrospective Observational Study to Evaluate the Clinical Outcomes and Routine Management of Patients with Chronic Lymphocytic Leukaemia Treated with Idelalisib and Rituximab in the UK and Ireland (RETRO‐idel).” British Journal of Haematology, vol. 194, no. 1, July 2021, pp. 69–77. EBSCOhost, https://doi.org/10.1111/bjh.17475.
APA
Eyre, T. A., Preston, G., Kagdi, H., Islam, A., Nicholson, T., Smith, H. W., Cursley, A. P., Ramroth, H., Xing, G., Gu, L., Rajakumaraswamy, N., & Fegan, C. (2021). A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO‐idel). British Journal of Haematology, 194(1), 69–77. https://doi.org/10.1111/bjh.17475
Chicago
Eyre, Toby A., Gavin Preston, Huseini Kagdi, Amin Islam, Toby Nicholson, Harry W. Smith, Adam P. Cursley, et al. 2021. “A Retrospective Observational Study to Evaluate the Clinical Outcomes and Routine Management of Patients with Chronic Lymphocytic Leukaemia Treated with Idelalisib and Rituximab in the UK and Ireland (RETRO‐idel).” British Journal of Haematology 194 (1): 69–77. doi:10.1111/bjh.17475.